ID: ALA2332839

Max Phase: Preclinical

Molecular Formula: C22H30N8O7

Molecular Weight: 518.53

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  N=C(N)NCCC[C@@H]1NC(=O)CNC(=O)C[C@@H](C(=O)O)NC(=O)[C@@H](c2ccccc2)NC(=O)CNC1=O

Standard InChI:  InChI=1S/C22H30N8O7/c23-22(24)25-8-4-7-13-19(34)27-11-17(33)30-18(12-5-2-1-3-6-12)20(35)29-14(21(36)37)9-15(31)26-10-16(32)28-13/h1-3,5-6,13-14,18H,4,7-11H2,(H,26,31)(H,27,34)(H,28,32)(H,29,35)(H,30,33)(H,36,37)(H4,23,24,25)/t13-,14-,18+/m0/s1

Standard InChI Key:  ZPLWVCHCWZALGS-SUNYJGFJSA-N

Associated Targets(Human)

Integrin alpha-IIb/beta-3 3481 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-6 509 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-5 589 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-3 2708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-5/beta-1 686 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 518.53Molecular Weight (Monoisotopic): 518.2237AlogP: -3.20#Rotatable Bonds: 6
Polar Surface Area: 244.70Molecular Species: ZWITTERIONHBA: 7HBD: 9
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.61CX Basic pKa: 12.85CX LogP: -5.65CX LogD: -5.65
Aromatic Rings: 1Heavy Atoms: 37QED Weighted: 0.10Np Likeness Score: 0.74

References

1. Bochen A, Marelli UK, Otto E, Pallarola D, Mas-Moruno C, Di Leva FS, Boehm H, Spatz JP, Novellino E, Kessler H, Marinelli L..  (2013)  Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids.,  56  (4): [PMID:23362923] [10.1021/jm301221x]

Source